Chromosomal microarray analysis for pregnancies with abnormal maternal serum screening who undergo invasive prenatal testing

Recently, chromosomal microarray analysis (CMA) has been implemented as a first‐tier test in pregnancies with ultrasound anomalies. However, its application for pregnancies with abnormal maternal serum screening (AMSS) only is not widespread. This study evaluated the value of CMA compared to traditi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Wu, Xiaoqing, Li, Ying, Lin, Na, Xie, Xiaorui, Su, Linjuan, Cai, Meiying, Lin, Yuan, Wang, Linshuo, Wang, Meiying, Xu, Liangpu, Huang, Hailong
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256361/
https://ncbi.nlm.nih.gov/pubmed/34042265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16589
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars